These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20261317)

  • 21. The immunization of troops with typhus vaccine and the characteristics of typhus in immunized individuals.
    SADUSK JF
    Yale J Biol Med; 1949 Jan; 21(3):211-32. PubMed ID: 18109885
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response of human subjects to epidemic typhus vaccine three to eight years after previous immunization.
    MURRAY ES; OFSTROCK A; SNYDER JC
    J Immunol; 1952 Feb; 68(2):207-18. PubMed ID: 14927925
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antigenic and immunogenic properties of dry typhus exanthematosus vaccine].
    KARASEVA PS
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Jul; 7():15-9. PubMed ID: 13196624
    [No Abstract]   [Full Text] [Related]  

  • 24. Concepts of louse-borne typhus control in developing countries: the use of the living attenuated E strain typhus vaccine in epidemic and endemic situations.
    Wisseman CL
    Adv Exp Med Biol; 1972; 31(0):97-130. PubMed ID: 4211883
    [No Abstract]   [Full Text] [Related]  

  • 25. On increasing the yield and potency of typhus vaccine prepared from infected yolk sacs.
    GROUPE V; NIGG C; MACFARLANE JO
    J Immunol; 1946 Aug; 53():303-14. PubMed ID: 20998814
    [No Abstract]   [Full Text] [Related]  

  • 26. An allergic reaction following typhus-fever vaccine and yellow-fever vaccine due to egg yolk sensitivity.
    RUBIN SS
    J Allergy; 1946 Jan; 17():21-3. PubMed ID: 21012466
    [No Abstract]   [Full Text] [Related]  

  • 27. [Laboratory contamination in vaccinated individuals, in exanthematic typhus].
    SILVA R; KOPCIOWSKA L
    Bull Soc Pathol Exot Filiales; 1945; 36(11-12):320-3. PubMed ID: 21024723
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemic typhus vaccine; antibody response to a single dose among persons previously vaccinated.
    GAULD RL; GOODNER K
    U S Armed Forces Med J; 1951 Sep; 2(9):1311-5. PubMed ID: 14867044
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on commercial typhus vaccines. III. The concentration and isolation of the Rickettsia-specific soluble antigen of commercial typhus vaccine.
    COHEN SS; CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):465-73. PubMed ID: 14794910
    [No Abstract]   [Full Text] [Related]  

  • 30. [Duration of efficacy of Rickettsial vaccine, formolized, and prepared by the Durand-Giroud method].
    HORRENBERGER R
    Arch Inst Pasteur Alger; 1950 Sep; 28(3):364-75. PubMed ID: 14800479
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on rickettsial toxin simplified potency-test of typhus vaccine in mice by direct challenge of the toxin.
    KITAOKA M; SHISHIDO A
    Jpn Med J (Natl Inst Health Jpn); 1950 Feb; 3(1):1-10. PubMed ID: 14774030
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of typhus vaccine on the numbers of rickettsiae in body lice of typhus patients.
    SNYDER JC; MURRAY ES
    Am J Hyg; 1949 May; 49(3):340-5. PubMed ID: 18126463
    [No Abstract]   [Full Text] [Related]  

  • 33. Rickettsial vaccines with emphasis on epidemic typhus. Initial report of an old vaccine trial.
    Woodward TE
    S Afr Med J; 1986 Oct; Suppl():73-6. PubMed ID: 3095934
    [No Abstract]   [Full Text] [Related]  

  • 34. Weil-Felix and complement-fixation test after typhus vaccine.
    KALRA SL; SPEECHLY CG
    Indian J Med Res; 1950 Jan; 38(1):1-2. PubMed ID: 15421676
    [No Abstract]   [Full Text] [Related]  

  • 35. LIVE TYPHUS VACCINE PREPARED FROM STRAIN "E" OF RICKETTSIA PROWAZEKI.
    GOLINEVICH EM; YABLONSKAYA VA
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():290-300. PubMed ID: 14113553
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined (associated) immunization against typhoid, typhus and plague].
    Gapochko KG; Misnikov OP; Kolkov VF; Kekcheeva NG; Semenova BN; Titova TS
    Voen Med Zh; 1994 Apr; (4):42-6, 79. PubMed ID: 8091696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Summary of current ideas on vaccination against tuberculosis].
    RODRIGUEZ GOMEZ A
    Rev Med Cir; 1949 Mar; 16(3):12-22. PubMed ID: 18118094
    [No Abstract]   [Full Text] [Related]  

  • 38. [On biological characteristics of vaccinal strain E of Rickettsia prowazekii (observations on the immunization of humans with live typhus vaccine)].
    PSHENICHNOV VA; LEVASHOV AA; NIKOLENKO VIa
    Vopr Virusol; 1959; 4():698-703. PubMed ID: 14435201
    [No Abstract]   [Full Text] [Related]  

  • 39. A reference, inactivated, epidemic typhus vaccine: clinical trials in man.
    Mason RA; Wenzel RP; Seligmann EB; Ginn RK
    J Biol Stand; 1976; 4(3):217-24. PubMed ID: 820697
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the behavior of vaccine antitifica agglutinins following nonspecific stimulus].
    RIVANO R
    G Batteriol Immunol; 1947 Jan; 35(6):361-6. PubMed ID: 20255424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.